Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kontrol Technologies Corp N.KNR

Alternate Symbol(s):  KNRLF

Kontrol Technologies Corp. is a provider of energy management, continuous air quality and emission solutions to commercial and industrial consumers. It delivers building intelligence through the Internet of things (IoT), software and cloud technology as well as project integration. Its smart technology is deployed to customers through a cloud-based interface accessible on desktops and mobile devices. It collects real-time and historical data using IoT sensors and direct connection to industrial control systems, bringing various sources of asset performance data into the cloud where smart-learning software is applied to optimize performance. The Company, through CEM Specialties Inc., offers turn-key emission monitoring equipment, integration design, manufacturing, service, repairs, and on-site performance certification testing. It offers building heating, ventilation, and air conditioning integration, automation and retrofits to enhance the energy efficiency of buildings and facilities.


NEO:KNR - Post by User

Comment by wilanderon Feb 22, 2021 7:04pm
109 Views
Post# 32632918

RE:I've read more about Jarry

RE:I've read more about JarryGee thats a tough one yank.

Jarry's "opinion" on something he's never seen

or 

those who have seen Biocloud and know how it works like The National Research Council of Canada

and

Caroline Duchaine, Ph.D.

Dr. Duchaine is a full-time professor in the Department of biochemistry, microbiology and bioinformatics, Unversit Laval, researcher at the Research Center of the l'Institut universitaire de cardiologie et de pneumologie de Qubec-Universit Laval. In 2000, she founded the bioaerosol research group, world leader in aerovirology, air microbiota analyzes, in vitro bioaerosols, industrial hygiene and agricultural health. She works closely with doctors, engineers, agronomists and physicists in order to develop transdisciplinary research projects aimed at understanding the role of bioaerosols in several contexts: public health, veterinary, agriculture, industry and hospitals. She has supervised more than 115 students and participated in more than 110 research projects, funded by provincial, national and international agencies. She has published 156 peer-reviewed manuscripts, 30 reports, 320 abstracts, and 65 invited lectures in addition to book chapters and scientific reports. She is part of numerous national and international committees and has chaired many international conference sessions. In addition to her undergraduate and graduate teaching involvement and young professors mentoring, she is regularly solicited by mass audience media and is active in knowledge translation. Professor Duchaine holds the Tier-1 Canada Research Chair in Bioaerosols and has been a FRQS and CIHR Scholar.

David E. Heinrichs, Ph.D.

Dr. Heinrichs received his Ph.D. in Microbiology & Immunology from Queen's University at Kingston was a postdoctoral fellow at the University of GuelphDr. Heinrichs is currently a professor of Microbiology & Immunology at the University of Western Ontario.

Dr. Heinrichs holds research grants to study the pathogenesis of the 'superbug' Staphylococcus aureus (MRSA) and is developing inhibitors as new therapeutic strategies against this pathogen. Recent work includes examining the effects of co-infection with MRSA and SARS-CoV-2.

Jimmy Dikeakos, Ph.D.

Dr. Dikeakos is an Associate Professor in the Department of Microbiology and Immunology at Western University and the current President of the Canadian Society for VirologyDr. Dikeakos obtained his B.Sc from McGill University and his PhD from the Universit de Montral. He then subsequently completed a Post-Doctoral fellowship with Dr. Gary Thomas at the Vollum Institute within the Oregon Health and Sciences University.

Since 2012, Dr. Dikeakos has directed a research lab specializing in HIV research at Western University where he supervises M.Sc, PhD, PDFs and 4th year Honors Thesis students. He has also taught hundreds of students introductory virology in his role as course co-coordinator of 2500A/B.


That's a real tough one.

<< Previous
Bullboard Posts
Next >>